Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding brain health in ICU patients with kidney injury

Official title: Identifying Neurocognitive Outcomes and Cerebral Oxygenation in Critically Ill Adults on Acute Kidney Replacement Therapy in the Intensive Care Unit

Run by Queen's University · NCT04722939 · Data updated 2026-11-12

This study looks at how kidney injury affects brain health in critically ill adults in the ICU to see if measuring brain oxygen levels can help predict long-term thinking and memory problems.

More Cognitive Impairment trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment104 (estimated)
SponsorQueen's University
Academic / other
Locations1 site (Kingston, Ontario)
StatusRecruiting
StartedJanuary 15, 2021
Main results expectedJanuary 1, 2026
Study endsJanuary 1, 2027
Registry record updatedDecember 26, 2023
Trial IDNCT04722939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are admitted to the ICU with severe acute kidney injury requiring kidney replacement therapy.

Probably not a fit

Patients with pre-existing neurological disorders or contraindications to cerebral oximetry testing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the neurocognitive outcomes of critically ill adults who have experienced acute kidney injury and are undergoing kidney replacement therapy. It focuses on measuring regional cerebral oxygen saturation as a potential early indicator of long-term cognitive impairment. By correlating these measurements with cognitive and functional outcomes, the study aims to shed light on the relationship between kidney therapy and brain health in ICU patients. The research is conducted at the Kingston Health Sciences Centre.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and interventions for cognitive impairment in ICU patients with acute kidney injury.

How similar studies have gone: While this study explores a specific aspect of cognitive outcomes in ICU patients, similar studies have indicated a link between kidney therapy and cognitive impairment, suggesting a potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age greater than or equal to 18 years
* admitted to the Kingston Health Sciences Intensive Care Unit
* diagnosis of severe AKI requiring Kidney Replacement Therapy (KRT) (defined by the presence of either a twofold increase in serum creatinine from baseline, serum creatinine level greater than or equal to 354 micromol/L with an increase of 27 micromol/L from baseline, or urine output \<6 mL/kg in the preceding 12 hours)
* within 12 hours of initiation of KRT via intermittent hemodialysis (iHD) or continuous kidney replacement therapy (CKRT).

Exclusion Criteria:

* acquired or congenital neurological disorders
* any contraindication to testing with cerebral oximetry, Kinarm, or MRI (e.g., claustrophobia, limb amputation, paresis, neuromuscular disorders, etc.)
* KRT via PD
* failure to consent
* life expectancy less than 24 hours
* clinical suspicion of renal obstruction
* rapidly progressive glomerulonephritis or interstitial nephritis
* prehospitalization eGFR \<30 mL/min/1.73m2.

Where it's running

  • Kingston Health Sciences Centre
    Kingston, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.